Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
Digestive Diseases and Sciences|March 10, 2009
Serum ferritin is a clinical biomarker in Japanese patients with nonalcoholic steatohepatitis (NASH) independent of HFE gene mutationMasato Yoneda, Yuichi Nozaki, Hiroki Endo, et al.Journal of Gastroenterology|March 17, 2005
Are bile duct lesions of primary biliary cirrhosis distinguishable from those of autoimmune hepatitis and chronic viral hepatitis? Interobserver histological agreement on trimmed bile ductsYoh Zen, Kenichi Harada, Motoko Sasaki, et al.International Journal of Molecular Sciences|January 16, 2014
Evaluation of hepatic tissue blood flow using xenon computed tomography with fibrosis progression in nonalcoholic fatty liver disease: comparison with chronic hepatitis CRyuta Shigefuku, Hideaki Takahashi, Masaki Kato, et al.Journal of Gastroenterology|May 29, 2007
Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stageMasato Yoneda, Hironori Mawatari, Koji Fujita, et al.Cell Metabolism|July 10, 2012
Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signalingKento Imajo, Koji Fujita, Masato Yoneda, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 8, 2006
Interobserver variation in the histopathological assessment of nonalcoholic steatohepatitisToshio Fukusato, Junichi Fukushima, Junji Shiga, et al.Journal of Gastroenterology|July 27, 2007
High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASHMasato Yoneda, Hironori Mawatari, Koji Fujita, et al.Liver International : Official Journal of the International Association for the Study of the Liver|March 24, 2009
Association between angiotensin II type 1 receptor polymorphisms and the occurrence of nonalcoholic fatty liver diseaseMasato Yoneda, Kikuko Hotta, Yuichi Nozaki, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 24, 2009
Influence of inducible nitric oxide synthase polymorphisms in Japanese patients with non-alcoholic fatty liver diseaseMasato Yoneda, Kikuko Hotta, Yuichi Nozaki, et al.BMC Gastroenterology|November 19, 2008
Plasma Pentraxin3 is a novel marker for nonalcoholic steatohepatitis (NASH)Masato Yoneda, Takashi Uchiyama, Shingo Kato, et al.Pageof 4